10.495 Molecular Design and Bioprocess Development of Immunotherapies
Examines challenges and opportunities for applying chemical engineering principles to address the growing global burden of infectious disease, including drug-resistant strains and neglected pathogens. Topics include a historical overview of vaccines and immunotherapies, the molecular design considerations for new immunotherapies and adjuvants, the economic challenges for process development and manufacturing of immunotherapies, and new technologies for designing and assessing therapies. Case studies to cover topics for specific diseases. Students taking graduate version complete additional assignments.
This class has 7.06 as a prerequisite.
10.495 will not be offered this semester. It will be available in the Spring semester, and will be instructed by J. C. Love.
This class counts for a total of 9 credits.
You can find more information at the http://www.google.com/search?&q=MIT+%2B+10.495&btnG=Google+Search&inurl=https site.
© Copyright 2015 Yasyf Mohamedali